165 related articles for article (PubMed ID: 37133752)
1. Transition of Care for Patients with Thalassemia.
Chandra J; Sahi PK
Indian J Pediatr; 2023 Dec; 90(12):1227-1231. PubMed ID: 37133752
[TBL] [Abstract][Full Text] [Related]
2. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia.
Thuret I; Ruggeri A; Angelucci E; Chabannon C
Stem Cells Transl Med; 2022 Apr; 11(4):407-414. PubMed ID: 35267028
[TBL] [Abstract][Full Text] [Related]
3. Decision-making about gene therapy in transfusion dependent thalassemia.
Quarmyne MO; Ross D; Sinha C; Bakshi N; Boudreaux J; Krishnamurti L
BMC Pediatr; 2022 Sep; 22(1):536. PubMed ID: 36085025
[TBL] [Abstract][Full Text] [Related]
4. Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy.
Porter J
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):361-370. PubMed ID: 30504333
[TBL] [Abstract][Full Text] [Related]
5. Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients.
Caocci G; La Nasa G; d'Aloja E; Vacca A; Piras E; Pintor M; Demontis R; Pisu S
BMC Med Ethics; 2011 Mar; 12():4. PubMed ID: 21385429
[TBL] [Abstract][Full Text] [Related]
6. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.
Marktel S; Scaramuzza S; Cicalese MP; Giglio F; Galimberti S; Lidonnici MR; Calbi V; Assanelli A; Bernardo ME; Rossi C; Calabria A; Milani R; Gattillo S; Benedicenti F; Spinozzi G; Aprile A; Bergami A; Casiraghi M; Consiglieri G; Masera N; D'Angelo E; Mirra N; Origa R; Tartaglione I; Perrotta S; Winter R; Coppola M; Viarengo G; Santoleri L; Graziadei G; Gabaldo M; Valsecchi MG; Montini E; Naldini L; Cappellini MD; Ciceri F; Aiuti A; Ferrari G
Nat Med; 2019 Feb; 25(2):234-241. PubMed ID: 30664781
[TBL] [Abstract][Full Text] [Related]
7. Health state utilities associated with treatment for transfusion-dependent β-thalassemia.
Matza LS; Paramore LC; Stewart KD; Karn H; Jobanputra M; Dietz AC
Eur J Health Econ; 2020 Apr; 21(3):397-407. PubMed ID: 31828456
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
Sii-Felice K; Giorgi M; Leboulch P; Payen E
Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
[TBL] [Abstract][Full Text] [Related]
9. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
[TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation.
Sriwichakorn C; Nakavachara P; Jitpirasakun S; Pooliam J; Sanpakit K
Pediatr Hematol Oncol; 2023 Feb; 40(1):1-13. PubMed ID: 35499955
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
Yesilipek MA
Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
[TBL] [Abstract][Full Text] [Related]
12. Common queries in thalassemia care.
Panigrahi I; Marwaha RK
Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation for children with thalassemia major in China.
Fang JP; Xu LH
Pediatr Blood Cancer; 2010 Dec; 55(6):1062-5. PubMed ID: 20979169
[TBL] [Abstract][Full Text] [Related]
14. Thalassemia: Common Clinical Queries in Management.
Lal A; Bansal D
Indian J Pediatr; 2020 Jan; 87(1):75-81. PubMed ID: 31620986
[TBL] [Abstract][Full Text] [Related]
15. Thalassemia Major: Transplantation or Transfusion and Chelation.
Mohamed SY
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
[TBL] [Abstract][Full Text] [Related]
16. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
18. Infusion of autologous retrodifferentiated stem cells into patients with beta-thalassemia.
Abuljadayel IS; Quereshi H; Ahsan T; Rizvi S; Ahmed T; Khan SM; Akhtar J; Dhoot G
ScientificWorldJournal; 2006 Oct; 6():1278-97. PubMed ID: 17041717
[TBL] [Abstract][Full Text] [Related]
19. Iron chelation therapy in the management of thalassemia: the Asian perspectives.
Viprakasit V; Lee-Lee C; Chong QT; Lin KH; Khuhapinant A
Int J Hematol; 2009 Nov; 90(4):435-445. PubMed ID: 19862602
[TBL] [Abstract][Full Text] [Related]
20. The Non-Adherence To Iron Chelation Therapy (ICT) Among Transfusion Dependent Thalassemia (TDT) Patients In Pakistan.
Arif F; Qazi Z; Maqsood A
J Pak Med Assoc; 2023 Sep; 73(9):1939. PubMed ID: 37817728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
